跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 13,525 条关于
“D3S 001”
全部
13,525
临床试验
5,850
药物
5,930
机构
60
资讯
1,685
2年前
D3S-001 Shows Superior KRAS G12C Inhibition with Rapid Target Engagement and Promising Clinical Activity
去年
D3S-001 Shows Breakthrough Efficacy as Next-Generation KRAS G12C Inhibitor in Multiple Cancer Types
111年前
D3Bio's Novel KRAS-G12C Inhibitor Shows Promising Results in Phase 1 Cancer Trial
去年
New Mainland Chinese Cancer Drug Shows Promising Results in Phase 1 Trial
9个月前
D3 Bio Raises $108 Million Series B to Advance Global Phase III Trials for KRAS G12C Inhibitor Elisrasib
2年前
Neuraptive's NTX-001 Receives FDA Breakthrough Therapy Designation for Peripheral Nerve Injury
去年
Insignis Therapeutics Receives Positive FDA Feedback for Needle-Free Anaphylaxis Treatment, IN-001
去年
CD Biopharma's CD-001 Receives FDA Clearance for Phase 1 Trial in Oncology
去年
Hoth Therapeutics' HT-001 Demonstrates 100% Success in Phase 2a Trial for Cancer Treatment Skin Toxicities
去年
Alkeus' Gildeuretinol Receives FDA Rare Pediatric Disease and Fast Track Designations for Stargardt Disease
第 1 页,共 169 页
上一页
下一页